Alterations in endogenous opioid functional measures in chronic back pain. 2013

Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
Molecular and Behavioral Neuroscience Institute, and Departments of Psychiatry, Anesthesiology, Obstetrics and Gynecology, and Radiology, University of Michigan, Ann Arbor, Michigan 48109, Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan 48104, Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109, and School of Dentistry, University of Maryland, Baltimore, Maryland 21201.

The absence of consistent end organ abnormalities in many chronic pain syndromes has led to a search for maladaptive CNS mechanisms that may explain their clinical presentations and course. Here, we addressed the role of brain regional μ-opioid receptor-mediated neurotransmission, one of the best recognized mechanisms of pain regulation, in chronic back pain in human subjects. We compared μ-opioid receptor availability in vivo at baseline, during pain expectation, and with moderate levels of sustained pain in 16 patients with chronic nonspecific back pain (CNBP) and in 16 age- and gender-matched healthy control subjects, using the μ-opioid receptor-selective radioligand [(11)C]carfentanil and positron emission tomography. We found that CNBP patients showed baseline increases in thalamic μ-opioid receptor availability, contrary to a previously studied sample of patients diagnosed with fibromyalgia. During both pain expectation and sustained pain challenges, CNBP patients showed regional reductions in the capacity to activate this neurotransmitter system compared with their control sample, further associated with clinical pain and affective state ratings. Our results demonstrate heterogeneity in endogenous opioid system functional measures across pain conditions, and alterations in both receptor availability and endogenous opioid function in CNBP that are relevant to the clinical presentation of these patients and the effects of opioid analgesics on μ-opioid receptors.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001931 Brain Mapping Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures. Brain Electrical Activity Mapping,Functional Cerebral Localization,Topographic Brain Mapping,Brain Mapping, Topographic,Functional Cerebral Localizations,Mapping, Brain,Mapping, Topographic Brain
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
January 2022, Frontiers in systems neuroscience,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
January 2014, Regional anesthesia and pain medicine,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
March 1994, Pain,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
September 2010, European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
April 2003, Mayo Clinic health letter (English ed.),
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
January 1996, The Journal of the American Board of Family Practice,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
January 1996, The Journal of the American Board of Family Practice,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
January 1996, The Journal of the American Board of Family Practice,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
March 2013, JAMA,
Ilkka K Martikainen, and Marta Peciña, and Tiffany M Love, and Emily B Nuechterlein, and Chelsea M Cummiford, and Carmen R Green, and Richard E Harris, and Christian S Stohler, and Jon-Kar Zubieta
April 1996, Scandinavian journal of medicine & science in sports,
Copied contents to your clipboard!